BNP Paribas Financial Markets’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36M | Sell |
454,649
-24,811
| -5% | -$1.87M | 0.01% | 934 |
|
|
2026
Q1 | $36M | Buy |
479,460
+144,852
| +43% | +$11.4M | 0.02% | 837 |
|
|
2025
Q4 | $26.5M | Sell |
334,608
-48,618
| -13% | -$3.66M | 0.01% | 1018 |
|
|
2025
Q3 | $25.1M | Buy |
383,226
+205,464
| +116% | +$10M | 0.01% | 991 |
|
|
2025
Q2 | $7.02M | Sell |
177,762
-130,531
| -42% | -$4.27M | ﹤0.01% | 1658 |
|
|
2025
Q1 | $9.3M | Buy |
308,293
+53,772
| +21% | +$1.76M | 0.01% | 1441 |
|
|
2024
Q4 | $8.9M | Buy |
254,521
+79,193
| +45% | +$2.96M | 0.01% | 1435 |
|
|
2024
Q3 | $7.02M | Sell |
175,328
-10,616
| -6% | -$494K | ﹤0.01% | 1326 |
|
|
2024
Q2 | $8.86M | Sell |
185,944
-8,415
| -4% | -$345K | 0.01% | 1154 |
|
|
2024
Q1 | $8.43M | Sell |
194,359
-160,596
| -45% | -$7.65M | 0.01% | 1158 |
|
|
2023
Q4 | $18M | Sell |
354,955
-55,719
| -14% | -$2.67M | 0.02% | 742 |
|
|
2023
Q3 | $18.6M | Buy |
410,674
+300,158
| +272% | +$12.4M | 0.02% | 633 |
|
|
2023
Q2 | $4.53M | Buy |
110,516
+11,401
| +12% | +$438K | 0.01% | 1284 |
|
|
2023
Q1 | $3.54M | Sell |
99,115
-92,832
| -48% | -$3.49M | 0.01% | 1461 |
|
|
2022
Q4 | $7.25M | Buy |
191,947
+59,207
| +45% | +$2.49M | 0.01% | 1120 |
|
|
2022
Q3 | $5.87M | Buy |
132,740
+12,770
| +11% | +$538K | 0.01% | 1297 |
|
|
2022
Q2 | $4.44M | Buy |
119,970
+29,034
| +32% | +$1.09M | 0.01% | 1297 |
|
|
2022
Q1 | $3.37M | Sell |
90,936
-215,317
| -70% | -$7.05M | ﹤0.01% | 1502 |
|
|
2021
Q4 | $9.32M | Buy |
306,253
+280,521
| +1,090% | +$8.83M | 0.01% | 1001 |
|
|
2021
Q3 | $863K | Buy |
25,732
+4,465
| +21% | +$168K | ﹤0.01% | 2466 |
|
|
2021
Q2 | $848K | Sell |
21,267
-7,373
| -26% | -$289K | ﹤0.01% | 2275 |
|
|
2021
Q1 | $1.29M | Sell |
28,640
-28,213
| -50% | -$1.57M | ﹤0.01% | 1988 |
|
|
2020
Q4 | $3.21M | Buy |
56,853
+10,135
| +22% | +$505K | 0.01% | 1375 |
|
|
2020
Q3 | $2.22M | Sell |
46,718
-16,115
| -26% | -$895K | ﹤0.01% | 1466 |
|
|
2020
Q2 | $3.7M | Sell |
62,833
-9,517
| -13% | -$529K | 0.01% | 1206 |
|
|
2020
Q1 | $3.42M | Sell |
72,350
-63,116
| -47% | -$3.52M | 0.01% | 1177 |
|
|
2019
Q4 | $8.18M | Buy |
135,466
+85,265
| +170% | +$5.08M | 0.01% | 950 |
|
|
2019
Q3 | $3.01M | Buy |
50,201
+4,780
| +11% | +$312K | 0.01% | 1296 |
|
|
2019
Q2 | $2.92M | Buy |
45,421
+29,613
| +187% | +$2.09M | 0.01% | 1284 |
|
|
2019
Q1 | $1.28M | Sell |
15,808
-14,552
| -48% | -$939K | ﹤0.01% | 1596 |
|
|
2018
Q4 | $1.64M | Buy |
30,360
+9,573
| +46% | +$488K | ﹤0.01% | 1400 |
|
|
2018
Q3 | $1.07M | Buy |
20,787
+3,650
| +21% | +$171K | ﹤0.01% | 1731 |
|
|
2018
Q2 | $714K | Buy |
17,137
+3,256
| +23% | +$144K | ﹤0.01% | 1867 |
|
|
2018
Q1 | $612K | Buy |
13,881
+3,319
| +31% | +$169K | ﹤0.01% | 2066 |
|
|
2017
Q4 | $531K | Sell |
10,562
-3,221
| -23% | -$177K | ﹤0.01% | 2435 |
|
|
2017
Q3 | $699K | Sell |
13,783
-3,469
| -20% | -$182K | ﹤0.01% | 1796 |
|
|
2017
Q2 | $878K | Buy |
17,252
+3,946
| +30% | +$184K | ﹤0.01% | 1614 |
|
|
2017
Q1 | $535K | Sell |
13,306
-7,350
| -36% | -$330K | ﹤0.01% | 1704 |
|
|
2016
Q4 | $988K | Sell |
20,656
-30,444
| -60% | -$1.2M | ﹤0.01% | 1326 |
|
|
2016
Q3 | $1.87M | Buy |
51,100
+32,982
| +182% | +$1.03M | 0.01% | 746 |
|
|
2016
Q2 | $422K | Buy |
18,118
+2,804
| +18% | +$90.5K | ﹤0.01% | 1579 |
|
|
2016
Q1 | $620K | Sell |
15,314
-14,490
| -49% | -$589K | ﹤0.01% | 1143 |
|
|
2015
Q4 | $1.85M | Buy |
29,804
+12,611
| +73% | +$680K | ﹤0.01% | 947 |
|
|
2015
Q3 | $695K | Sell |
17,193
-193,125
| -92% | -$10M | ﹤0.01% | 1201 |
|
|
2015
Q2 | $12.1M | Buy |
210,318
+207,132
| +6,501% | +$13.2M | 0.03% | 306 |
|
|
2015
Q1 | $203K | Buy |
3,186
+3,140
| +6,826% | +$213K | ﹤0.01% | 1560 |
|
|
2014
Q4 | $2.84K | Sell |
46
-6,871
| -99% | -$339K | ﹤0.01% | 1849 |
|
|
2014
Q3 | $269K | Sell |
6,917
-1,049
| -13% | -$37.2K | ﹤0.01% | 1756 |
|
|
2014
Q2 | $274K | Buy |
7,966
+7,928
| +20,863% | +$250K | ﹤0.01% | 1710 |
|
|
2014
Q1 | $1.01K | Sell |
38
-1,419
| -97% | -$68.8K | ﹤0.01% | 2862 |
|
|
2013
Q4 | $58K | Sell |
1,457
-37,658
| -96% | -$1.34M | ﹤0.01% | 1857 |
|
|
2013
Q3 | $1.47M | Sell |
39,115
-1,000,448
| -96% | -$29.9M | ﹤0.01% | 1016 |
|
|
2013
Q2 | $176M | Buy |
+1,039,563
| New | +$22.1M | 0.12% | 99 |
|
Other funds holding IONS
VPM
VCM
BNP Paribas Financial Markets's IONS Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Ionis Pharmaceuticals (IONS) stake by 5.2% in Q2 2026, selling an estimated $1.87M and leaving 454,649 shares worth $36M. The position accounts for 0.01% of the portfolio, ranked #934.
BNP Paribas Financial Markets first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. The position peaked at $176M in Q2 2013. 476 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- BNP Paribas Financial Markets held 454,649 shares of Ionis Pharmaceuticals worth $36M as of Q2 2026.
- BNP Paribas Financial Markets sold 24,811 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.87M.
- Ionis Pharmaceuticals made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #934 holding.
- BNP Paribas Financial Markets first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Ionis Pharmaceuticals position peaked at $176M in Q2 2013.
- 476 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.